Comparing two antibiotics for fever with low white blood cells in children with blood cancer
Treatments studied
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial compares two antibiotics, ciprofloxacin and ceftazidime, to see which works better for treating fever in children with blood cancer who have a high risk of infection due to low white blood cells. The goal is to find the best treatment to help your child recover faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 0 and 18 years old.
- Your child has a blood cancer, such as leukemia or lymphoma.
- Your child currently has a fever with low white blood cells (called high-risk neutropenic fever).
- Your child has not had an allergic reaction to ciprofloxacin or ceftazidime before.
- Your child's fever is not from a blood transfusion.
- Your child has not taken other antibiotics (except certain preventive ones) in the last 3 days.
- Your child's kidneys and liver are working properly.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how antibiotics are used in the emergency department for patients who may have a low white blood cell count (neutropenic fever) after cancer treatment. The goal is to ensure antibiotics are used appropriately and effectively without causing harm.
This trial tests whether an antibiotic called ceftazidime-avibactam (CAZ-AVI) can help patients with blood cancers who have a fever and very low infection-fighting white blood cells. It may be an option for people whose doctors plan to use this specific antibiotic to treat their fever.
This trial tests whether a single antibiotic (amoxicillin-clavulanate) works as well as taking two antibiotics (amoxicillin-clavulanate plus ciprofloxacin) for fever caused by chemotherapy in people with certain blood cancers. The goal is to treat the fever at home, avoiding a hospital stay, while keeping you safe and comfortable.
This trial looks at whether adding a medicine called G-CSF (which helps the body make more white blood cells) to antibiotics is better than antibiotics alone for children with cancer who develop a fever and low blood cell counts after chemotherapy.
This trial compares stopping antibiotics early (after fever resolves) versus continuing them as usual in adults with blood cancers who develop fever during treatment. It aims to find the best timing to reduce unnecessary antibiotic use.
This study looks at how a certain antibiotic (ceftazidime-avibactam) works in people with blood cancers or stem cell transplants, and how the drug levels affect the bacteria. It aims to find the best dosing to fight infections and reduce resistance.
Hear when a new Neutropenic Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.